trimethyloxamine has been researched along with Kidney Failure in 8 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethylamine (TMA) is a tertiary amine with a characteristic fishy odour." | 2.53 | The complex metabolism of trimethylamine in humans: endogenous and exogenous sources. ( Bhargava, B; Chhibber-Goel, J; Gaur, A; Parakh, N; Sharma, A; Singhal, V, 2016) |
| "In individuals with type 1 diabetes, higher concentrations of plasma TMAO were associated with mortality, CVD events, and poor renal outcome, independent of conventional risk factors." | 1.51 | Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. ( Ahluwalia, TS; Hansen, TW; Hazen, SL; Jorsal, A; Parving, HH; Pedersen, O; Rossing, P; Tarnow, L; Theilade, S; Tofte, N; Wang, Z; Winther, SA; Øllgaard, JC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mafra, D | 1 |
| Kemp, JA | 1 |
| Leal, VO | 1 |
| Cardozo, L | 1 |
| Borges, NA | 1 |
| Alvarenga, L | 1 |
| Teixeira, KTR | 1 |
| Stenvinkel, P | 1 |
| Wang, M | 1 |
| Li, XS | 2 |
| Wang, Z | 3 |
| de Oliveira Otto, MC | 1 |
| Lemaitre, RN | 1 |
| Fretts, A | 1 |
| Sotoodehnia, N | 1 |
| Budoff, M | 1 |
| Nemet, I | 1 |
| DiDonato, JA | 1 |
| Tang, WHW | 1 |
| Psaty, BM | 1 |
| Siscovick, DS | 1 |
| Hazen, SL | 3 |
| Mozaffarian, D | 1 |
| Korytowska-Przybylska, N | 1 |
| Michorowska, S | 1 |
| Wyczałkowska-Tomasik, A | 1 |
| Pączek, L | 1 |
| Giebułtowicz, J | 1 |
| Li, W | 1 |
| Huang, A | 1 |
| Zhu, H | 1 |
| Liu, X | 1 |
| Huang, X | 1 |
| Huang, Y | 2 |
| Cai, X | 1 |
| Lu, J | 1 |
| Winther, SA | 1 |
| Øllgaard, JC | 1 |
| Tofte, N | 1 |
| Tarnow, L | 1 |
| Ahluwalia, TS | 1 |
| Jorsal, A | 1 |
| Theilade, S | 1 |
| Parving, HH | 1 |
| Hansen, TW | 1 |
| Pedersen, O | 1 |
| Rossing, P | 1 |
| Tang, WH | 1 |
| Kennedy, DJ | 1 |
| Wu, Y | 1 |
| Buffa, JA | 1 |
| Agatisa-Boyle, B | 1 |
| Levison, BS | 1 |
| Fogelman, AM | 1 |
| Chhibber-Goel, J | 1 |
| Gaur, A | 1 |
| Singhal, V | 1 |
| Parakh, N | 1 |
| Bhargava, B | 1 |
| Sharma, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4: a Protocol of a Randomized, Parallel, Controlled Trial[NCT03596749] | Phase 3 | 80 participants (Anticipated) | Interventional | 2018-09-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for trimethyloxamine and Kidney Failure
| Article | Year |
|---|---|
Consumption of Fish in Chronic Kidney Disease - A Matter of Depth.
Topics: Animals; Gastrointestinal Microbiome; Methylamines; Renal Insufficiency; Renal Insufficiency, Chroni | 2023 |
Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Topics: Cause of Death; Gastrointestinal Microbiome; Heart Failure; Heart Transplantation; Hospitalization; | 2020 |
The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.
Topics: Air Pollutants; Animals; Atherosclerosis; Diet; Humans; Metabolism, Inborn Errors; Methylamines; Neo | 2016 |
5 other studies available for trimethyloxamine and Kidney Failure
| Article | Year |
|---|---|
Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Topics: Adult; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Dementia; Humans; Methylamines; Neoplas | 2023 |
Development of a novel method for the simultaneous detection of trimethylamine N-oxide and creatinine in the saliva of patients with chronic kidney disease - Its utility in saliva as an alternative to blood.
Topics: Biomarkers; Creatinine; Humans; Methylamines; Renal Insufficiency; Renal Insufficiency, Chronic; Sal | 2023 |
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Topics: Aged; Biomarkers; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diabetic Nephropathies; Fema | 2019 |
Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Animals; Biomarkers; Case-Control Studies; Female; Humans; Intestines; Male | 2015 |
TMAO is both a biomarker and a renal toxin.
Topics: Animals; Female; Humans; Male; Methylamines; Microbiota; Renal Insufficiency; Renal Insufficiency, C | 2015 |